Carolyn L. Gall Casey, BASc

Director Guidelines and Knowledge Translation
Canadian Cardiovascular Society

Disclosure information not submitted.

Presentation(s):

• 140 - CCS/CHFS 2025 GUIDELINE UPDATE FOR PHARMACOLOGIC MANAGEMENT OF HEART FAILURE WITH NON-REDUCED EJECTION FRACTION (LV EJECTION FRACTION > 40%)

  Thursday, October 23, 2025
  2:00pm - 3:00pm ET

• 266 - CCS/CHRS GUIDELINE FOR THE MANAGEMENT OF CARDIAC IMPLANTABLE ELECTRONIC DEVICES

  Friday, October 24, 2025
  4:30pm - 5:30pm ET

• 303 - THE CANADIAN CARDIOVASCULAR SOCIETY SECONDARY PREVENTION PATHWAY: A NEW RESOURCE TO SUPPORT LONG-TERM POST-ACUTE CORONARY SYNDROME CARE

  Saturday, October 25, 2025
  8:30am - 9:30am ET

• 345 - CCS/NATIONAL ADVISORY COMMITTEE JOINT STATEMENT ON BLOOD UTILIZATION/TRANSFUSION FOR PATIENTS WITH CARDIOVASCULAR DISEASE

  Saturday, October 25, 2025
  2:00pm - 3:00pm ET

• 365 - CCS CLINICAL PRACTICE UPDATE ON THE CLINICAL IMPLEMENTATION OF CARDIOGENETIC TESTING

  Saturday, October 25, 2025
  4:30pm - 5:30pm ET

• 422 - CCS GUIDELINES RAPID REVIEW SESSION 1

  Sunday, October 26, 2025
  10:00am - 11:00am ET

• 432 - CCS GUIDELINES RAPID REVIEW SESSION 2

  Sunday, October 26, 2025
  11:15am - 12:15pm ET